Notice of Closed Meeting, 474 [2019-00275]
Download as PDF
<![CDATA[
474
Federal Register / Vol. 84, No. 20 / Wednesday, January 30, 2019 / Notices
The meeting will be held on
March 14, 2019, 2:00 p.m. to 5:00 p.m.,
EDT (CLOSED).
DATES:
ADDRESSES:
Teleconference.
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
National Institutes of Health
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–3953,
Email address: NCIPCBSC@cdc.gov.
[FR Doc. 2019–00298 Filed 1–29–19; 8:45 am]
The
meeting will be closed to the public in
accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the
Chief Operating Officer, Office of the
Chief Operating Officer, CDC, pursuant
to Public Law 92–463.
Purpose: The Board of Scientific
Counselors makes recommendations
regarding policies, strategies, objectives,
and priorities; and reviews progress
toward injury and violence prevention.
The Board also provides advice on the
appropriate balance of intramural and
extramural research, and guidance on
the needs, structure, progress and
performance of intramural programs.
The Board also provides guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of secondary peer review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as they
relate to the Center’s programmatic
balance and mission; (3) submission of
secondary review recommendations to
the Center Director relating to
applications to be considered for
funding support; (4) review of research
portfolios, and (5) review of program
proposals.
Matters to be Considered: The agenda
will include discussions on Secondary
Peer Review of extramural research
grant and cooperative agreement
applications received in response to one
(1) Notice of Funding Opportunities
(NOFO): CE19–001, Injury Control
Research Centers. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Centers for Disease Control and
Prevention
SUPPLEMENTARY INFORMATION:
amozie on DSK3GDR082PROD with NOTICES1
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Sep<11>2014
16:22 Jan 29, 2019
Jkt 247001
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—DP19–005, Research
to Enhance the US Vision and Eye Health
Surveillance System.
Dates: March 28, 2019.
Times: 11:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer, CDC,
4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–6511,
kva5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00275 Filed 1–29–19; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, DDK–C Member
Conflicts.
Date: February 15, 2019.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
7111, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00292 Filed 1–29–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 84, Number 20 (Wednesday, January 30, 2019)]
[Notices]
[Page 474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00275]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--DP19-005, Research to
Enhance the US Vision and Eye Health Surveillance System.
Dates: March 28, 2019.
Times: 11:00 a.m.-6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00275 Filed 1-29-19; 8:45 am]
BILLING CODE 4163-18-P
